title: Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells.
abstract: Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor in adults. Current therapy includes surgery, radiation and chemotherapy with temozolomide (TMZ). Major determinants of clinical response to TMZ include methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter and mismatch repair (MMR) status. Though the MGMT promoter is methylated in 45% of cases, for the first nine months of follow-up, TMZ does not change survival outcome. Furthermore, MMR deficiency makes little contribution to clinical resistance, suggesting that there exist unrecognized mechanisms of resistance. We generated paired GBM cell lines whose resistance was attributed to neither MGMT nor MMR. We show that, responding to TMZ, these cells exhibit a decoupling of DNA damage response (DDR) from ongoing DNA damages. They display methylation-resistant synthesis in which ongoing DNA synthesis is not inhibited. They are also defective in the activation of the S and G2 phase checkpoint. DDR proteins ATM, Chk2, MDC1, NBS1 and gammaH2AX also fail to form discrete foci. These results demonstrate that failure of DDR may play an active role in chemoresistance to TMZ. DNA damages by TMZ are repaired by MMR proteins in a futile, reiterative process, which activates DDR signaling network that ultimately leads to the onset of cell death. GBM cells may survive genetic insults in the absence of DDR. We anticipate that our findings will lead to more studies that seek to further define the role of DDR in ultimately determining the fate of a tumor cell in response to TMZ and other DNA methylators.
authors.affiliation: Departments of Surgery.
authors.forename: Bo
authors.initials: B
authors.lastname: Cui
authors.forename: Stewart P
authors.initials: SP
authors.lastname: Johnson
authors.forename: Nancy
authors.initials: N
authors.lastname: Bullock
authors.forename: Francis
authors.initials: F
authors.lastname: Ali-Osman
authors.forename: Darell D
authors.initials: DD
authors.lastname: Bigner
authors.forename: Henry S
authors.initials: HS
authors.lastname: Friedman
keywords: DNA damage response; glioblastomas multiforme; resistance; temozolomide
references.citation: Br J Cancer. 2007 Mar 26;96(6):960-9
references.pmid: 17342095
references.citation: N Engl J Med. 2000 Nov 9;343(19):1350-4
references.pmid: 11070098
references.citation: Clin Cancer Res. 2008 Aug 1;14(15):4859-68
references.pmid: 18676759
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1091-101
references.pmid: 15279797
references.citation: Mol Pharmacol. 2004 Sep;66(3):478-91
references.pmid: 15322239
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):2038-45
references.pmid: 17404084
references.citation: Clin Cancer Res. 2002 Aug;8(8):2725-34
references.pmid: 12171906
references.citation: Am J Pathol. 1989 Jan;134(1):53-61
references.pmid: 2913827
references.citation: DNA Repair (Amst). 2008 Oct 1;7(10):1705-16
references.pmid: 18644472
references.citation: Cancer Res. 1992 Oct 1;52(19):5373-8
references.pmid: 1356617
references.citation: Nature. 2003 Feb 27;421(6926):952-6
references.pmid: 12607003
references.citation: Nat Struct Mol Biol. 2006 May;13(5):451-7
references.pmid: 16622404
references.citation: Oncogene. 2007 Jan 11;26(2):186-97
references.pmid: 16819506
references.citation: Mol Cancer Ther. 2006 Oct;5(10):2531-9
references.pmid: 17041097
references.citation: Oncogene. 2003 Apr 10;22(14):2110-20
references.pmid: 12687013
references.citation: Nat Clin Pract Neurol. 2005 Dec;1(2):88-95
references.pmid: 16932504
references.citation: J Biol Chem. 2001 May 18;276(20):16848-56
references.pmid: 11279128
references.citation: Carcinogenesis. 2001 Dec;22(12):1931-7
references.pmid: 11751422
references.citation: Nat Genet. 2003 Jan;33(1):80-4
references.pmid: 12447371
references.citation: Pharmacol Res. 2007 Oct;56(4):275-87
references.pmid: 17897837
references.citation: N Engl J Med. 2005 Mar 10;352(10):997-1003
references.pmid: 15758010
references.citation: Cancer Res. 2005 Jun 1;65(11):4861-9
references.pmid: 15930307
references.citation: Nat Genet. 2002 Mar;30(3):290-4
references.pmid: 11850621
references.citation: Mol Cell. 2004 Apr 9;14(1):105-16
references.pmid: 15068807
references.citation: Nature. 2003 Feb 27;421(6926):957-61
references.pmid: 12607004
references.citation: Nucleic Acids Res. 1992 Jun 25;20(12):2933-40
references.pmid: 1620587
references.citation: Chem Biol Interact. 1971 Oct;3(5):337-42
references.pmid: 5156328
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11200-5
references.pmid: 18678890
references.citation: Oncogene. 2004 Jan 15;23(2):359-67
references.pmid: 14724564
references.citation: Mol Cancer Ther. 2006 Nov;5(11):2757-66
references.pmid: 17121922
references.citation: Nat Cell Biol. 2003 May;5(5):401-9
references.pmid: 12717439
references.citation: Nature. 2007 May 10;447(7141):218-21
references.pmid: 17429352
references.citation: Carcinogenesis. 2006 Apr;27(4):682-92
references.pmid: 16332722
references.citation: Proc Natl Acad Sci U S A. 1990 Aug;87(15):5837-41
references.pmid: 2116007
references.citation: Science. 2000 Mar 10;287(5459):1824-7
references.pmid: 10710310
references.citation: Mol Cell. 2006 May 19;22(4):501-10
references.pmid: 16713580
references.citation: N Engl J Med. 2008 Jul 31;359(5):492-507
references.pmid: 18669428
references.citation: Cancer Res. 2006 Apr 15;66(8):3987-91
references.pmid: 16618716
references.citation: Nat Cell Biol. 2008 Apr;10(4):460-7
references.pmid: 18344987
references.citation: Proc Natl Acad Sci U S A. 1980 Dec;77(12):7315-7
references.pmid: 6938978
references.citation: Nature. 2001 Apr 12;410(6830):842-7
references.pmid: 11298456
references.citation: Mol Cancer Ther. 2002 Jul;1(9):727-36
references.pmid: 12479369
references.citation: Chem Biol Interact. 1971 Oct;3(5):343-51
references.pmid: 5156329
references.citation: EMBO J. 2002 Oct 1;21(19):5195-205
references.pmid: 12356735
references.citation: J Biol Chem. 2006 Oct 13;281(41):30814-23
references.pmid: 16905549
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: Cell Cycle. 2005 Mar;4(3):473-7
references.pmid: 15684614
references.citation: Cancer Cell. 2008 Jan;13(1):11-22
references.pmid: 18167336